수의용 항감염제 시장 규모, 점유율, 성장 분석 : 제품 유형별, 동물 유형별, 투여 경로별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Veterinary Anti-Infectives Market size was valued at USD 8.6 Billion in 2024 and is poised to grow from USD 9.22 Billion in 2025 to USD 16.08 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global veterinary anti-infectives market is primarily driven by the increasing demand for effective infection control in both livestock and companion animals. This market includes a variety of products such as antibiotics, antivirals, antifungals, and diagnostics that are crucial for maintaining animal health, which directly impacts food security, public health, and economic livelihoods. Growth in this sector is fueled by intensified farming practices and a rise in pet ownership, prompting pharmaceutical innovations and regulatory scrutiny. Key factors influencing market dynamics include the challenge of antimicrobial resistance and its implications for veterinary practices. As resistance escalates, there is a heightened demand for rapid diagnostics, narrow-spectrum agents, and alternative treatments, alongside advancements driven by AI that enhance diagnostics and antimicrobial stewardship.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Anti-Infectives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Anti-Infectives Market Segments Analysis

Global veterinary anti-infectives market is segmented by product type, animal type, route of administration, distribution channel, end user and region. Based on product type, the market is segmented into Antibiotics, Antivirals, Antifungals and Antiparasitic Anti-infectives. Based on animal type, the market is segmented into Companion Animals and Livestock Animals. Based on route of administration, the market is segmented into Oral, Injectable, Topical, Intramammary and Others. Based on distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, E-commerce and Feed Mills & Agricultural Supply Stores. Based on end user, the market is segmented into Veterinary Hospitals & Clinics, Animal Farms, Pet Owners and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Anti-Infectives Market

One key market driver for the global veterinary anti-infectives market is the increasing prevalence of infectious diseases in livestock and companion animals. The rising awareness among pet owners and livestock producers about the health and welfare of animals has heightened the demand for effective treatments. Furthermore, regulatory developments aimed at enhancing animal health, combined with the growth in the livestock sector due to the demand for protein-rich food sources, create a substantial need for veterinary anti-infectives. Advancements in research and development of novel therapeutics are also contributing to market growth, addressing the challenges posed by antibiotic resistance and the need for alternative solutions.

Restraints in the Global Veterinary Anti-Infectives Market

One key market restraint for the global veterinary anti-infectives market is the increasing incidence of antimicrobial resistance (AMR). The rising prevalence of resistant bacterial strains in both human and veterinary medicine poses significant challenges to the efficacy of existing anti-infective treatments. This not only limits the options available for veterinarians in effectively managing infections but also raises concerns regarding public health and food safety. Regulatory bodies are increasingly scrutinizing the approval and use of antimicrobial agents, leading to stricter regulations and guidelines. These factors can hinder market growth and innovation in developing new anti-infective products for veterinary use.

Market Trends of the Global Veterinary Anti-Infectives Market

The Global Veterinary Anti-Infectives market is witnessing a significant trend fueled by the increasing demand for companion animal healthcare. Pet owners are increasingly prioritizing preventive care and effective treatment options, leading to a surge in the adoption of veterinary anti-infectives. This trend is further driven by the premiumization of pet products, heightened engagement with veterinary services, and rising expectations for treatment outcomes. In response, manufacturers are innovating with targeted formulations and convenient dosing methods, while also investing in strategic partnerships and tailored educational programs for veterinary practitioners and pet owners. As a result, branded therapeutics and chronic care pathways are gaining prominence in the veterinary pharmaceutical sector.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Anti-infectives Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Antibiotics
  • Tetracyclines
  • Penicillins
  • Cephalosporins
  • Macrolides
  • Sulfonamides
  • Fluoroquinolones
  • Aminoglycosides
  • Others
• Antivirals
  • Livestock Antivirals
  • Companion Animal Antivirals
  • Others
• Antifungals
  • Topical Antifungals
  • Systemic Antifungals
• Antiparasitic Anti-infectives

Global Veterinary Anti-infectives Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Livestock Animals
  • Cattle
  • Poultry
  • Swine
  • Sheep & Goats
  • Aquaculture
  • Others

Global Veterinary Anti-infectives Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical
• Intramammary
• Others

Global Veterinary Anti-infectives Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Veterinary Pharmacies
• E-commerce
• Feed Mills & Agricultural Supply Stores

Global Veterinary Anti-infectives Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Animal Farms
• Pet Owners
• Others

Global Veterinary Anti-infectives Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endovac Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chanelle Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashish Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations